Statutory Instrument 1995 No. 2321

      The Medicines Act 1968 (Amendment) Regulations 1995


      © Crown Copyright 1995

      Statutory Instruments printed from this website are printed under the superintendence and authority of the Controller of HMSO being the Queen's Printer of Acts of Parliament.

      The legislation contained on this web site is subject to Crown Copyright protection. It may be reproduced free of charge provided that it is reproduced accurately and that the source and copyright status of the material is made evident to users.

      It should be noted that the right to reproduce the text of Statutory Instruments does not extend to the Queen's Printer imprints which should be removed from any copies of the Statutory Instrument which are issued or made available to the public. This includes reproduction of the Statutory Instrument on the Internet and on intranet sites. The Royal Arms may be reproduced only where they are an integral part of the original document.

      The text of this Internet version of the Statutory Instrument which is published by the Queen's Printer of Acts of Parliament has been prepared to reflect the text as it was Made. A print version is also available and is published by The Stationery Office Limited as the The Medicines Act 1968 (Amendment) Regulations 1995, ISBN 0110534271. The print version may be purchased by clicking here. Braille copies of this Statutory Instrument can also be purchased at the same price as the print edition by contacting TSO Customer Services on 0870 600 5522 or e-mail:customer.services@tso.co.uk.

      Further information about the publication of legislation on this website can be found by referring to the Frequently Asked Questions.

      To ensure fast access over slow connections, large documents have been segmented into "chunks". Where you see a "continue" button at the bottom of the page of text, this indicates that there is another chunk of text available.

 


STATUTORY INSTRUMENTS

1995 No. 2321

MEDICINES

The Medicines Act 1968 (Amendment) Regulations 1995

Made 5th September 1995
Laid before Parliament 6th September 1995
Coming into force 29th September 1995

    The Secretary of State and the Minister of Agriculture, Fisheries and Food, acting jointly in exercise of the powers conferred on them by section 2(2) of the European Communities Act 1972[1], being designated for the purposes of that section in relation to medicinal products[2], hereby make the following Regulations:
    Citation and commencement
        1.    These Regulations may be cited as the Medicines Act 1968 (Amendment) Regulations 1995 and shall come into force on 29th September 1995.
    Amendment
        2.    In section 96 of the Medicines Act 1968 (advertisements and representations directed to practitioners)[3], after subsection (6) there is inserted the following subsection—
      "  (7)  Nothing in this section applies in relation to a relevant medicinal product, as defined by paragraph (1) of regulation 2 of the Medicines (Advertising) Regulations 1994[4], in respect of which there is required to exist a summary of product characteristics as defined by that paragraph."



Stephen Dorrell

One of Her Majesty's Principal Secretaries of State

5th September 1995

Angela Browning

Parliamentary Secretary Ministry of Agriculture, Fisheries and Food

4th September 1995






EXPLANATORY NOTE

(This note is not part of the Regulations)
    These Regulations, made under powers contained in section 2(2) of the European Communities Act 1972, deal with matters related to the implementation of Council Directive 92/28/EEC (OJ No. L113, 30.4.92, p.13) ("the Advertising Directive"). The Advertising Directive, which was implemented principally by the Medicines (Advertising) Regulations 1994 (S.I. 1994/1932), provides that advertising of a relevant medicinal product must be based on the provisions of that product's summary of product characteristics. Requirements for the contents of summaries of product characteristics are set out in Article 4a of Directive 65/65/EEC (OJ No. L22, 9.2.65, p.369/65; relevant amending Directives are 83/570/EEC (OJ No. L332, 28.11.83, p.1) and 89/341/EEC (OJ No. L142, 25.05.89, p.11)). The Advertising Directive also sets out the circumstances in which summaries of product characteristics are to be made available to health professionals. These provisions differ from those contained in the Medicines Act 1968.
    Regulation 2 adds subsection (7) to section 96 of the Medicines Act 1968 (which deals with advertisements and representations directed to practitioners), so that that section does not apply in relation to any medicinal product governed by the provisions of the Medicines (Advertising) Regulations 1994 and which is required to have a summary of product characteristics.



ISBN 0 11 053427 1




Notes:

[1] 1972 c. 68. back

[2] S.I. 1972/1811. back

[3] 1968 c. 67. back

[4] S.I. 1994/1932, amended by S.I. 1994/3144. back

 

Other UK SIs | Home | National Assembly for Wales Statutory Instruments | Scottish Statutory Instruments | Statutory Rules of Northern Ireland | Her Majesty's Stationery Office

We welcome your comments on this site
© Crown copyright 1995
Prepared 20th September 2000